SEC Tracker
Get the app

Shuttle Pharmaceuticals Holdings SHPH

Shuttle Pharmaceuticals dismisses auditor

Item 4.01 Changes auditor

Form
8-K
Filed
Importance
Major
  1. Dismissal of Forvis Mazars effective after Q3 2026 10-Q filing
  2. No disagreements with auditor on accounting matters
  3. Material weaknesses in internal controls identified
  4. No new auditor engaged as of Oct 22, 2026

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Shuttle Pharmaceuticals Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Soligenix SNGX public float $5M, Jun 30, 2025
  2. China Pharma Holdings CPHI public float $4M, Jun 30, 2025
  3. Skinvisible SKVI public float $5M, Jun 30, 2025
  4. Theriva Biologics TOVX public float $4M, Jun 30, 2025
  5. Polomar Health Services PMHS public float $4M, Jun 30, 2025